Buprenorphine/Samidorphan Combination for the Adjunctive Treatment of Major Depressive Disorder: Results of a Phase III Clinical Trial (FORWARD-3)
Neuropsychiatric Disease and Treatment
doi 10.2147/ndt.s199245
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Informa UK Limited